Nomura Asset Management CO LTD Bluebird Bio, Inc. Transaction History

Nomura Asset Management CO LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$18.04 - $22.09 $0 - $0	0 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.59 - $33.89 $0 - $0	0 New	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	BUY	$34.44 - $43.75 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $0 - $0	0 New	0 $0
Q1 2020 May 14, 2020	BUY	$26.16 - $63.5 $0 - $0	0 New	0 $0
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$59.47 - $93.1 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$75.84 - $105.21 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $0 - $0	0 New	0 $0
Q4 2018 Feb 12, 2019	SELL	$59.1 - $93.26 $118,200 - $186,520	-2,000 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$99.64 - $127.59 $411,911 - $527,457	-4,134 Reduced 67.39%	2,000 $314,000
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $437,377 - $623,985	4,134 Added 206.7%	6,134 $1.05 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $162,500 - $261,399	2,000 New	2,000 $356,000
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $0 - $0	0	0 $0

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.